Fund Tracker India by Ishaan Dungarwal
Guide

ITI Pharma and Healthcare Fund

Managed by Animesh Singh and Nilay Dalal.

Fund managers: Animesh Singh; Nilay Dalal

Benchmark: Nifty Healthcare Total Return Index · Riskometer: Very High · SEBI category, as filed: Sectoral/Thematic Funds · Allotted 8 Nov 2021

Source: AMFI scheme summary document

Compare

NAV

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

Source: AMFI

₹20.700420 Nov 2026
AUM

average for July - September 2026, all plans.

Source: AMFI

₹266 crJuly - September 2026
Expense ratio

The scheme's yearly running cost as a % of its assets, taken out of the NAV a little each day. A regular plan costs more: it pays a distributor's commission.

Category median: direct 1.23 %, regular 2.40 % (174 schemes) · Regular costs ₹1,710 more a year per ₹1 lakh

Of this, the base expense ratio, the part SEBI caps: direct 0.58 %, regular 2.10 %. The rest is brokerage, transaction costs and statutory levies such as GST and STT, as AMFI's file lists them.

A year, as of 21 Nov 2026. Source: AMFI · Glossary: TER

Direct 0.86 %Regular 2.57 %
ITI Mutual Fund's monthly portfolios are not on this site.

Returns next to the benchmark

What the plan's NAV did over each period, as AMFI publishes it.

as of 19 Nov 2026 · as published by AMFI
PeriodDirect planRegular planBenchmark, as published by AMFI NIFTY Healthcare TRI
1 year+17.08 %+15.02 %+16.99 %
3 years+19.86 %+17.66 %+20.62 %
5 years+15.60 %+13.34 %+15.61 %
Since launch+15.41 %+13.15 %+15.60 %

Past performance may not be sustained in future.

Source: AMFI fund performance

As AMFI's fund performance report prints them for "ITI Pharma & Healthcare Fund"; this site computes no benchmark figure of its own.

How to read

How it is computed: NAV to NAV

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option: these run to the newest NAV stored (20 Nov 2026) and are computed here from AMFI's NAV files; AMFI's figures above run to 19 Nov 2026, so the two differ by the days in between.

PeriodReturnFromTo
1 year+18.01 % in total 20 Nov 2025 · NAV ₹17.541920 Nov 2026 · NAV ₹20.7004
3 years+19.94 % a year, compounded 20 Nov 2023 · NAV ₹11.991020 Nov 2026 · NAV ₹20.7004
5 years+15.73 % a year, compounded 18 Nov 2021 · NAV ₹9.957720 Nov 2026 · NAV ₹20.7004
Since first NAV+15.56 % a year, compounded 11 Nov 2021 · NAV ₹10.005520 Nov 2026 · NAV ₹20.7004

Source: AMFI NAV files (plan code 149268). How to read Report a wrong number

Not enough NAV history stored yet for rolling returns and a monthly SIP.

IDCW (dividend) history

0 declarations · as of 2 Nov 2026 · Source: AMFI
AMFI lists no IDCW declared by this scheme.
Source: AMFI scheme dividends. How to read

IDCW (formerly "dividend") declared per unit of each IDCW plan, as AMFI lists it.

Calendar-year returns, ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

NAV to NAV · Source: AMFI
YearReturnFromTo
2025−8.24 % 31 Dec 2024 · NAV ₹18.596131 Dec 2025 · NAV ₹17.0636
2024+43.95 % 29 Dec 2023 · NAV ₹12.918331 Dec 2024 · NAV ₹18.5961
2023+34.39 % 30 Dec 2022 · NAV ₹9.612529 Dec 2023 · NAV ₹12.9183
2022−6.68 % 31 Dec 2021 · NAV ₹10.301030 Dec 2022 · NAV ₹9.6125

Past performance may not be sustained in future.

Change in the plan's NAV over each calendar year, last NAV to last NAV. Source: AMFI NAV files. How to read

Embed this card

Card for this scheme: facts with source and date

Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.

From AMFI's own files (scheme summary documents, NAV history, TER), as they stood on the day shown.

All schemes of ITI Mutual Fund →

Mutual fund investments are subject to market risks; read all scheme related documents carefully.